New York, New York--(Newsfile Corp. - September 29, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Unicycive Therapeutics, Inc. ("Unicycive" or "the Company") (NASDAQ: UNCY) and certain of its officers. Case DetailsThe Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. There is No Cost to YouWe represent investors in class actions on a contingency fee basis. Why Bronstein, Gewirtz & GrossmanBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.